Lee G. Wilke, MD Print Friendly Page
Faculty, University of Wisconsin School of Medicine and Public HealthDr. Lee Wilke specializes in benign and malignant diseases of the breast; sentinel lymph-node mapping; neoadjuvant therapy for breast cancer; nipple sparing breast surgery and minimally invasive surgery of the breast.
Dr. Wilke earned her medical degree from Duke University in Durham, N.C., and completed her residency and a research fellowship at the University of Michigan in Ann Arbor, Mich. She is certified by the American Board of Surgery and is the Director of the UW Health Breast Center.
Specialties
UW Health Clinics
Hospital Affiliation(s)
University of Wisconsin Hospital and Clinics (primary)
Meriter Hospital (secondary)
Languages Spoken
| English |
| Medical interpreters are available to help patients communicate with hospital and clinic staff. For more information, please contact interpreter services at (608) 262-9000. |
UW School of Medicine and Public Health
| Department of Surgery |
Professional Certifications and Education
| Board Certification |
Surgery
|
| Fellowship |
ACS Resident Research Fellow in Immunotherapy, University of Michigan Hospitals, Ann Arbor, MI 1996-1998 |
| Residency |
University of Michigan Hospitals, Ann Arbor
|
| Internship |
University of Michigan Hospitals, Ann Arbor
|
| Medical School |
Duke University School of Medicine, Durham, NC, 1993
|
Awards/Honors
Procedures
Our doctors provide a wide range of services. The following list represents some, but not all, of the procedures offered by this physician.
- Axillary Lymph Node Dissection
- Breast Biopsy
- Lumpectomy
- Mastectomy
- Needle-localized Excision
- Nipple-sparing Mastectomy
- Sentinel Lymph Node Biopsy
- Skin-sparing Mastectomy
Programs & Conditions
- Breast Cancer
- Breast Center
| Research |
Dr. Wilke’s main research interest are clinical trials that seek novel methods of treating breast cancer. She is a member of the executive committee of the American College of Surgeons Oncology Group, and also is a collaborator and investigator evaluating the use of optical spectroscopy to evaluate breast tumor margins and aid in the diagnosis and evaluation of solid tumors. |
PubMed Articles
-
Esbona K Li Z Wilke LG .
Intraoperative imprint cytology and frozen section pathology for margin assessment in breast conservation surgery: a systematic review. Ann Surg Oncol. 2012 Oct;19(10):3236-45
[PubMed ID: 22847119]
-
Caretta-Weyer H Sisney GA Beckman C Burnside ES Salkowsi LR Strigel RM Wilke LG Neuman HB .
Impact of axillary ultrasound and core needle biopsy on the utility of intraoperative frozen section analysis and treatment decision making in women with invasive breast cancer. Am J Surg. 2012 Sep;204(3):308-14
[PubMed ID: 22483606]
-
Cuneo KC Dash RC Wilke LG Horton JK Koontz BF .
Risk of invasive breast cancer and ductal carcinoma in situ in women with atypical papillary lesions of the breast. Breast J. 2012 Sep;18(5):475-8
[PubMed ID: 22776070]
-
Decker MR Greenblatt DY Havlena J Wilke LG Greenberg CC Neuman HB .
Impact of neoadjuvant chemotherapy on wound complications after breast surgery. Surgery. 2012 Sep;152(3):382-8
[PubMed ID: 22739071]
-
Ibarra-Drendall C Troch MM Barry WT Broadwater G Petricoin EF 3rd Wulfkuhle J Liotta LA Lem S Baker JC Jr Ford AC Wilke LG Zalles C Kuderer NM Hoffman AW Shivraj M Mehta P Williams J Tolbert N Lee LW Pilie PG Yu D Seewaldt VL .
Pilot and feasibility study: prospective proteomic profiling of mammary epithelial cells from high-risk women provides evidence of activation of pro-survival pathways. Breast Cancer Res Treat. 2012 Apr;132(2):487-98
[PubMed ID: 21647677]
-
Bydlon TM Barry WT Kennedy SA Brown JQ Gallagher JE Wilke LG Geradts J Ramanujam N .
Advancing optical imaging for breast margin assessment: an analysis of excisional time, cautery, and patent blue dye on underlying sources of contrast. PLoS One. 2012;7(12):e51418
[PubMed ID: 23251526]
-
Latosinsky S Cheifetz RE Wilke LG .
Survival analysis of cancer risk reduction strategies for BRCA1/2 mutation carriers. J Am Coll Surg. 2011 Sep;213(3):447-50
[PubMed ID: 21871383]
-
Pilie PG Ibarra-Drendall C Troch MM Broadwater G Barry WT Petricoin EF 3rd Wulfkuhle JD Liotta LA Lem S Baker JC Jr Stouder A Ford AC Wilke LG Zalles CM Mehta P Williams J Shivraj M Su Z Geradts J Yu D Seewaldt VL .
Protein microarray analysis of mammary epithelial cells from obese and nonobese women at high risk for breast cancer: feasibility data. Cancer Epidemiol Biomarkers Prev. 2011 Mar;20(3):476-82
[PubMed ID: 21242333]
-
Clifford EJ De Vol EB Pockaj BA Wilke LG Boughey JC .
Early results from a novel quality outcomes program: the American Society Of Breast Surgeons' Mastery of Breast Surgery. Ann Surg Oncol. 2010 Oct;17 Suppl 3:233-41
[PubMed ID: 20853039]
-
Wilke LG Ballman KV McCall LM Giuliano AE Whitworth PW Blumencranz PW Reintgen DS Burak WE Leitch AM Hunt KK .
Adherence to the National Quality Forum (NQF) breast cancer measures within cancer clinical trials: a review from ACOSOG Z0010. Ann Surg Oncol. 2010 Aug;17(8):1989-94
[PubMed ID: 20309640]
-
Bydlon TM Kennedy SA Richards LM Brown JQ Yu B Junker MK Gallagher J Geradts J Wilke LG Ramanujam N .
Performance metrics of an optical spectral imaging system for intra-operative assessment of breast tumor margins. Opt Express. 2010 Apr 12;18(8):8058-76
[PubMed ID: 20588651]
-
Wilke LG Nelson H Ota DM .
Promoting patient safety through peer review. Bull Am Coll Surg. 2010 Mar;95(3):45-6
[PubMed ID: 21456407]
-
Brown JQ Bydlon TM Richards LM Yu B Kennedy SA Geradts J Wilke LG Junker M Gallagher J Barry W Ramanujam N .
Optical assessment of tumor resection margins in the breast. IEEE J Sel Top Quantum Electron. 2010 Mar 1;16(3):530-544
[PubMed ID: 21544237]
-
Wilke LG Broadwater G Rabiner S Owens E Yoon S Ghate S Scott V Walsh R Baker J Soo MS Ibarra-Drendall C Stouder A Robertson S Barron A Seewaldt V .
Breast self-examination: defining a cohort still in need. Am J Surg. 2009 Oct;198(4):575-9
[PubMed ID: 19800471]
-
Wilke LG Brown JQ Bydlon TM Kennedy SA Richards LM Junker MK Gallagher J Barry WT Geradts J Ramanujam N .
Rapid noninvasive optical imaging of tissue composition in breast tumor margins. Am J Surg. 2009 Oct;198(4):566-74
[PubMed ID: 19800470]
-
Ibarra-Drendall C Wilke LG Zalles C Scott V Archer LE Lem S Yee LD Lester J Kulkarni S Murekeyisoni C Wood M Wilson K Garber J Gentry C Stouder A Broadwater G Baker JC Jr Vasilatos SN Owens E Rabiner S Barron AC Seewaldt VL .
Reproducibility of random periareolar fine needle aspiration in a multi-institutional Cancer and Leukemia Group B (CALGB) cross-sectional study. Cancer Epidemiol Biomarkers Prev. 2009 May;18(5):1379-85
[PubMed ID: 19383884]
-
Brown JQ Wilke LG Geradts J Kennedy SA Palmer GM Ramanujam N .
Quantitative optical spectroscopy: a robust tool for direct measurement of breast cancer vascular oxygenation and total hemoglobin content in vivo. Cancer Res. 2009 Apr 1;69(7):2919-26
[PubMed ID: 19293184]
-
Vasilatos SN Broadwater G Barry WT Baker JC Jr Lem S Dietze EC Bean GR Bryson AD Pilie PG Goldenberg V Skaar D Paisie C Torres-Hernandez A Grant TL Wilke LG Ibarra-Drendall C Ostrander JH D'Amato NC Zalles C Jirtle R Weaver VM Seewaldt VL .
CpG island tumor suppressor promoter methylation in non-BRCA-associated early mammary carcinogenesis. Cancer Epidemiol Biomarkers Prev. 2009 Mar;18(3):901-14
[PubMed ID: 19258476]
-
Ramanujam N Brown J Bydlon TM Kennedy SA Richards LM Junker MK Gallagher J Barry WT Wilke LG Geradts J .
Quantitative spectral reflectance imaging device for intraoperative breast tumor margin assessment. Conf Proc IEEE Eng Med Biol Soc. 2009;2009:6554-6
[PubMed ID: 19964903]
-
Baker JC Jr Ostrander JH Lem S Broadwater G Bean GR D'Amato NC Goldenberg VK Rowell C Ibarra-Drendall C Grant T Pilie PG Vasilatos SN Troch MM Scott V Wilke LG Paisie C Rabiner SM Torres-Hernandez A Zalles CM Seewaldt VL .
ESR1 promoter hypermethylation does not predict atypia in RPFNA nor persistent atypia after 12 months tamoxifen chemoprevention. Cancer Epidemiol Biomarkers Prev. 2008 Aug;17(8):1884-90
[PubMed ID: 18708376]
-
Bean GR Bryson AD Pilie PG Goldenberg V Baker JC Jr Ibarra C Brander DM Paisie C Case NR Gauthier M Reynolds PA Dietze E Ostrander J Scott V Wilke LG Yee L Kimler BF Fabian CJ Zalles CM Broadwater G Tlsty TD Seewaldt VL .
Morphologically normal-appearing mammary epithelial cells obtained from high-risk women exhibit methylation silencing of INK4a/ARF. Clin Cancer Res. 2007 Nov 15;13(22 Pt 1):6834-41
[PubMed ID: 18006786]
